Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Orally administered Kampo medicine, Juzen-taiho-to, ameliorates anemia during interferon plus ribavirin therapy in patients with chronic hepatitis C.

Sho Y, Fujisaki K, Sakashita H, Yamaguchi K, Tahara K, Kubozono O, Ido A, Tsubouchi H.

J Gastroenterol. 2004 Dec;39(12):1202-4.

PMID:
15622486
[PubMed - indexed for MEDLINE]
2.

[The adherence in the treatment of chronic hepatitis C].

Pawłowska M, Halota W.

Pol Merkur Lekarski. 2005 Apr;18(106):469-72. Review. Polish.

PMID:
16161937
[PubMed - indexed for MEDLINE]
3.

Ribavirin in the treatment of chronic hepatitis C.

Martin P, Jensen DM.

J Gastroenterol Hepatol. 2008 Jun;23(6):844-55. doi: 10.1111/j.1440-1746.2008.05398.x. Review.

PMID:
18565019
[PubMed - indexed for MEDLINE]
4.

Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C.

Chang CH, Chen KY, Lai MY, Chan KA.

Aliment Pharmacol Ther. 2002 Sep;16(9):1623-32. Review.

PMID:
12197841
[PubMed - indexed for MEDLINE]
Free Article
5.

[Crohn's disease associated with interferon and ribavirin treatment for chronic hepatitis C].

Khalil A, Lucidarme D, Desurmont P, Hamdan-Khalil R, Filoche B.

Gastroenterol Clin Biol. 2005 Feb;29(2):193-6. Review. French.

PMID:
15795671
[PubMed - indexed for MEDLINE]
Free Article
6.

Epoetin alfa for the treatment of combination therapy-induced hemolytic anemia in patients infected with hepatitis C virus.

Rivkin AM, Chawla S.

Pharmacotherapy. 2005 Jun;25(6):862-75. Review.

PMID:
15927905
[PubMed - indexed for MEDLINE]
7.

Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy.

McHutchison JG, Manns MP, Brown RS Jr, Reddy KR, Shiffman ML, Wong JB.

Am J Gastroenterol. 2007 Apr;102(4):880-9. Review.

PMID:
17397412
[PubMed - indexed for MEDLINE]
8.

[Side effects of interferon therapy for chronic hepatitis C].

Arase Y.

Nihon Rinsho. 2006 Jul;64(7):1363-7. Review. Japanese.

PMID:
16838657
[PubMed - indexed for MEDLINE]
9.

[Treatment of chronic hepatitis C: side effects, tolerability and quality of life].

Gournay J, Richou C.

Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B60-75. Review. French. No abstract available.

PMID:
12180310
[PubMed - indexed for MEDLINE]
10.

[Prevention of adverse effects in ribavirin and interferon combination therapy].

Izumi N.

Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):523-7. Review. Japanese. No abstract available.

PMID:
15359855
[PubMed - indexed for MEDLINE]
11.

Irritability: an underappreciated side effect of interferon treatment for chronic hepatitis C?

Blacklaws H, Gardner A, Usher K.

J Clin Nurs. 2011 May;20(9-10):1215-24. doi: 10.1111/j.1365-2702.2010.03494.x. Epub 2011 Mar 3. Review.

PMID:
21371144
[PubMed - indexed for MEDLINE]
12.

Literature review in cases with exacerbation of ulcerative colitis induced by treatment with interferon and/or ribavirin.

Watanabe T, Hirono H, Hasegawa K, Soga K, Shibasaki K.

J Gastroenterol Hepatol. 2011 Dec;26(12):1709-16. doi: 10.1111/j.1440-1746.2011.06890.x. Review.

PMID:
22097938
[PubMed - indexed for MEDLINE]
13.

Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C: case report and review of the literature.

Midturi J, Sierra-Hoffman M, Hurley D, Winn R, Beissner R, Carpenter J.

Clin Infect Dis. 2004 Dec 1;39(11):1724-9. Epub 2004 Nov 8. Review.

PMID:
15578378
[PubMed - indexed for MEDLINE]
Free Article
14.

The role of physician extenders in managing patients with chronic hepatitis C.

Gujral H, Viscomi C, Collantes R.

Cleve Clin J Med. 2004 May;71 Suppl 3:S33-7. Review.

PMID:
15468616
[PubMed - indexed for MEDLINE]
Free Article
15.

A Kampo medicine "Juzen-taiho-to"--prevention of malignant progression and metastasis of tumor cells and the mechanism of action.

Saiki I.

Biol Pharm Bull. 2000 Jun;23(6):677-88. Review.

PMID:
10864015
[PubMed - indexed for MEDLINE]
16.

Interferon-induced granulomatous lung disease.

Marzouk K, Saleh S, Kannass M, Sharma OP.

Curr Opin Pulm Med. 2004 Sep;10(5):435-40. Review.

PMID:
15316444
[PubMed - indexed for MEDLINE]
17.

Toxicological aspects of Kampo medicines in clinical use.

Ikegami F, Fujii Y, Ishihara K, Satoh T.

Chem Biol Interact. 2003 Jun 15;145(3):235-50. Review.

PMID:
12732452
[PubMed - indexed for MEDLINE]
18.

Toxicological considerations of Kampo medicines in clinical use.

Ikegami F, Fujii Y, Satoh T.

Toxicology. 2004 May 20;198(1-3):221-8. Review.

PMID:
15138045
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk